Product Details for ANDA 091193
BACLOFEN (BACLOFEN)
0.05MG/ML
Marketing Status: Prescription
0.5MG/ML
Marketing Status: Prescription
2MG/ML
Marketing Status: Prescription
0.05MG/ML
Marketing Status: Prescription
Active Ingredient: BACLOFEN
Proprietary Name: BACLOFEN
Dosage Form; Route of Administration: INJECTABLE; INTRATHECAL
Strength: 0.05MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A091193
Product Number: 001
Approval Date: May 3, 2016
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
BACLOFEN (BACLOFEN)
Proprietary Name: BACLOFEN
Dosage Form; Route of Administration: INJECTABLE; INTRATHECAL
Strength: 0.05MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A091193
Product Number: 001
Approval Date: May 3, 2016
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
0.5MG/ML
Marketing Status: Prescription
Active Ingredient: BACLOFEN
Proprietary Name: BACLOFEN
Dosage Form; Route of Administration: INJECTABLE; INTRATHECAL
Strength: 0.5MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A091193
Product Number: 002
Approval Date: May 3, 2016
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
BACLOFEN (BACLOFEN)
Proprietary Name: BACLOFEN
Dosage Form; Route of Administration: INJECTABLE; INTRATHECAL
Strength: 0.5MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A091193
Product Number: 002
Approval Date: May 3, 2016
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
2MG/ML
Marketing Status: Prescription
Active Ingredient: BACLOFEN
Proprietary Name: BACLOFEN
Dosage Form; Route of Administration: INJECTABLE; INTRATHECAL
Strength: 2MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A091193
Product Number: 003
Approval Date: May 3, 2016
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: BACLOFEN
Dosage Form; Route of Administration: INJECTABLE; INTRATHECAL
Strength: 2MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A091193
Product Number: 003
Approval Date: May 3, 2016
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information